Response: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India
- PMID: 35698851
- PMCID: PMC9350201
- DOI: 10.1002/ijgo.14291
Response: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India
Comment on
-
Letter to the Editor: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.Int J Gynaecol Obstet. 2022 Aug;158(2):494. doi: 10.1002/ijgo.14289. Epub 2022 Jun 14. Int J Gynaecol Obstet. 2022. PMID: 35698856 Free PMC article. No abstract available.
References
-
- U.S. Food and Drug Administration . EUA authorized serology test performance. https://www.fda.gov/medical‐devices/coronavirus‐disease‐2019‐covid‐19‐em... . Last accessed 27th April, 2022
-
- World Health Organization . Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https://www.who.int/publications/m/item/summary‐of‐probable‐sars‐cases‐w....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
